| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Kallikrein 8/Neuropsin Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 37-39 kDa, reducing conditions. MW (theoretical): 26 kDa. The Recombinant Human Kallikrein 8/Neuropsin Protein from R&D Systems is derived from NS0. The Recombinant Human Kallikrein 8/Neuropsin Protein has been validated for the following applications: Enzyme Activity. |
|---|
| Size | 10 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Enzyme Activity |
|---|
| Other Names | EC 3.4.21, EC 3.4.21.118, hK8, HNP, kallikrein 8 (neuropsin/ovasin), kallikrein-related peptidase 8, KLK8, KLK8 protein type 1, KLK8 protein type 2, Neuropsin, neuropsin type 1, neuropsin type 2, NP, NRPN, Ovasin, PRSS19, PRSS19kallikrein-8, Serine protease 19, Serine protease TADG-14, TADG14neuropsin, Tumor-associated differentially expressed gene 14 protein |
|---|
| Gene, Accession, CAS # | KLK8, Gene ID: 11202, Accession: O60259 |
|---|
| Catalog # | 2025-SE-010 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Kallikrein 8/Neuropsin Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 17823117, 19527222, 20667819, 21439340, 21508957 |
|---|
| 产品资料 |
|
|